Marksans Pharma Limited
Share Price Target & Analysis
NSE:MARKSANS
VWAP
Open
Close
High
Low
52 Week High
-1.00 (-0.3%)
MARKSANS
(PHARMA)Trending & Favourite
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: MARKSANS Share Price Financial Analysis & Valuation
Marksans Pharma Limited (MARKSANS) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Small Cap company with Market Capitalization of Rs 2308.5 (in Cr). Total number of free float shares are 40.9 (in Lacs).
Marksans Pharma Limited is listed on NSE with Exchange ID - INE750C01026 and trading code is NSE:MARKSANS with short name Marksans Pharma.
In the past 1 year, Marksans Pharma Limited has declared an equity dividend of Rs 0.27 per share. At the current share price of MARKSANS at Rs 329.40, this results in a dividend yield of 0.08 %.
As per the Fundamental Analysis of NSE:MARKSANS, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine MARKSANS underlying value and future prospects. All of this data is available in MARKSANS financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:MARKSANS, it is clearly understood that MARKSANS is Economical performer in terms of earnings and profit margins with an EPS of 7.4. NSE:MARKSANS book value per share as of today is 37.99. The current price to book ratio for MARKSANS as of Sep 13, 2026 is 8.67.
Valuation of the Stock: The current valuation of MARKSANS stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of MARKSANS whether to BUY this stock at current valuation. The delivery percentage of MARKSANS is 455488% is very crucial parameter which shows that 455488% investors are anticipating that the price of MARKSANS share should go up with VWAP at 328.98.
Now, the main question is whether to BUY or SELL, NSE:MARKSANS at current valuation.
As per latest Analysis No. #2829:-
⇑ STRONG BUY MARKSANS if All Greens
⇗ BUY MARKSANS (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD MARKSANS (With Stop Loss) if only 1 Green
⇘ SELL MARKSANS if NO Green Indicator
NSE: MARKSANS Share Price Today (Sep 13, 2026)
(Marksans Pharma Limited Daily Analysis on the basis of MARKSANS Intraday Graph & Trend)
Marksans Pharma Limited share price moved Down by -0.3% from its previous close of Rs 330.4. MARKSANS stock last traded price is 329.40. MARKSANS share price trend is Down with a total of 1631430 stocks traded till now. It has touched an intraday high of Rs 333.75 and an intraday low of Rs 324.2. The MARKSANS trading at 329.40, Down by Rs. -1.00, or -0.3 percent which suggests that most of the Traders are anticipating that the price of MARKSANS share should go Down.
NSE: MARKSANS Share Price Tomorrow Prediction
(Marksans Pharma Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of MARKSANS)
Marksans Pharma Limited share price moved Down by -0.3%. MARKSANS share price short term trend is Down. It suggests that MARKSANS Share Price for Tomorrow remains the same with VWAP at 328.98 will be treated as stop loss for intraday traders. Marksans Pharma Limited Long term investors can follow the MARKSANS long term trend as mentiond in future forecast table.
NSE Code |
NSE: MARKSANS |
MARKSANS Share Price Today |
329.40 |
MARKSANS Share Price Target Prediction for 2026 ^ |
243.1 - 351.7 |
MARKSANS Share Price Target Prediction for 2027*^ |
351.7 - 374.7 |
MARKSANS Share Price Target Prediction for 2028*^ |
374.7 - 400.9 |
MARKSANS Share Price Target Prediction for 2029*^ |
421 |
MARKSANS Share Price Target Prediction for 2030*^ |
433 |
MARKSANS Share Price Target Prediction for 2035*^ |
472 |
| MARKSANS Current Book Value |
37.8 |
*Marksans Pharma Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^MARKSANS share price target prediction for 2026 2027 2028 2029 2030 to 2035 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
MARKSANS Technical Analysis
Candlestick Pattern: @330.15| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 332.01 | SELL | 331.52 | SELL |
| MA_12 | 328.14 | BUY | 326.79 | BUY |
| MA_20 | 326.47 | BUY | 320.53 | BUY |
| MA_32 | 302.35 | BUY | 308.02 | BUY |
| MA_50 | 290.37 | BUY | 295.55 | BUY |
| MA_100 | 266.62 | BUY | 271.83 | BUY |
| MA_200 | 217.45 | BUY | 240.84 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 326.47 | Uptrend |
| MACD | -1.42 | SELL |
| ADX | 40.41 | Strong Trend |
| DMI (+/-) | 28.23 / 12.74 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 60.7 | Neutral |
| STOCHASTIC_K (Fast) | 33.64 | Neutral |
| STOCHASTIC_D (Slow) | 54.74 | Neutral |
| CCI | 71.08 | Neutral |
| PSAR | 313.84 | BUY |
| TRUE RANGE | 11.35 | Neutral |
| ATR | 13.35 | Neutral |
| WILLIAMS R | -53.73 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 58.12 | Neutral |
| MOMENTUM | 51.2 | BUY |
| Duration | Value |
|---|---|
| 1 Year | 92.42% |
| 3 Months | 30.62% |
| 1 Month | 18.35% |
| 1 Week | -0.71% |
| Action | Overall (%) |
|---|---|
| BUY | 57% |
| NEUTRAL / HOLD | 30% |
| SELL | 13% |
Most popular Questions & Answers about MARKSANS (/ FAQ MARKSANS)
Marksans Pharma Limited stock last traded price is 329.40. MARKSANS share price moved Down by -0.3% from its previous close of Rs 330.4.
Marksans Pharma Limited share price trend is Down with a total of 1631430 stocks traded till now. It has touched an intraday high of Rs 353.4495 and an intraday low of Rs 324.2. The MARKSANS trading at 329.40, Down by Rs. -1.00, or -0.3 percent which suggests that most of the Traders are anticipating that the price of MARKSANS share should go Down and the Stop Loss will be around 328.98.
The market cap of Marksans Pharma Limited is ₹2308.5 (in Cr) as of Sep 12, 2026.
The current price to earning ratio for Marksans Pharma Limited as of Sep 12, 2026 is 46.39.
The current price to book ratio for Marksans Pharma Limited as of Sep 12, 2026 is 8.67.
The highest price of Marksans Pharma Limited stock is ₹349.95 in the last 52-week.
The lowest price of Marksans Pharma Limited stock is ₹155 in the last 52-week.
Marksans Pharma Limited share trading at ₹329.40, Down by Rs. -1.00, or -0.3 percent which suggests that most of the traders are anticipating that the price of MARKSANS share should go Down.
In 2026, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹243.1 on downside and ₹351.7 on upside. Marksans Pharma Limited share price target is based on current financial year earings of the company.
In 2027, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹351.7 on downside and ₹374.7 on upside. Marksans Pharma Limited share price target is based on forecasted future earnings of the company.
In 2028, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹374.7 on downside and ₹400.9 on upside. Marksans Pharma Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Marksans Pharma Limited (MARKSANS) will be around ₹433 Marksans Pharma Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of MARKSANS.
The price of Marksans Pharma Limited (MARKSANS) shares moved by -0.3%. The short-term trend for MARKSANS share price is Down. It implies that the share price of MARKSANS will stay the same tomorrow and that intraday traders should treat VWAP at 328.98 as a stop loss. Investors with a long-term outlook can track MARKSANS long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of MARKSANS stock is 88.7. Compared to the current market price of 329.40 INR, the MARKSANS stock is Overvalued by 73.1%.
As per the fundamental analysis of Marksans Pharma Limited (MARKSANS), it is of Economical quality in terms of earnings and profit margins with an EPS of 7.4. Marksans Pharma Limited book value per share as of today is 37.99. The current price to book ratio for MARKSANS as of Sep 13, 2026 is 8.67.
NSE:MARKSANS News & Other Useful Information about MARKSANS Share Price
Peer Comparison of NSE: MARKSANS
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1840.00 | 16.35 | 97.89 |
| DIVISLAB | 9322.00 | 115.55 | 663.06 |
| MEDICAMEQ | 323.05 | 12.15 | 208.08 |
| CIPLA | 1366.00 | 51.67 | 434.03 |
| DRREDDY | 1165.50 | 53.19 | 380.63 |
| TORNTPHARM | 4965.50 | 87.32 | 235.7 |
| BIOCON | 390.65 | 1.27 | 166.51 |
| LUPIN | 2095.00 | 154.86 | 718.37 |
| ALKEM | 5087.50 | 212.33 | 1218.48 |
| AUROPHARMA | 1679.80 | 46.49 | 403.84 |
| ABBOTINDIA | 25550.00 | 766.11 | 2448.41 |
| GLAXO | 2828.40 | 63.65 | 147.25 |
| IPCALAB | 1968.50 | 56.72 | 329.23 |
| LAURUSLABS | 1969.00 | 20.74 | 102.57 |
| LALPATHLAB | 1909.00 | 39.68 | 157.23 |
| PFIZER | 4060.20 | 170.54 | 963.41 |
| AJANTPHARM | 3533.40 | 89.3 | 363.23 |
| SANOFI | 3079.20 | 158.05 | 332.96 |
| NATCOPHARM | 815.35 | 82.14 | 481.67 |
| APLLTD | 810.95 | 48.4 | 295.69 |
| JBCHEPHARM | 2408.90 | 54.16 | 251.48 |
| GLENMARK | 2419.20 | 1.24 | 881.78 |
| AAREYDRUGS | 98.89 | 2.39 | 53.38 |
| JUBLPHARMA | 1025.20 | 4.35 | 145.63 |
| SPARC | 196.01 | 48.14 | 40.45 |
| GRANULES | 909.30 | 23.25 | 180.42 |
| ASTRAZEN | 6764.50 | 86.44 | 364.29 |
| CAPLIPOINT | 2754.90 | 55.52 | 285.6 |
| FDC | 341.45 | 21.19 | 161.21 |
| HIKAL | 224.95 | 9.34 | 96.63 |